Laeyendecker O

Cross-sectional HIV incidence surveillance: a benchmarking of approaches for estimating the ‘mean duration of recent infection’
Kassanjee R, De Angelis D, Farah M, Hanson DL, Labuschagne JPL, Laeyendecker O, Le Vu S, Tom B, Wang R, Welte A

Statistical Communications in Infectious Diseases

(2017)

https://doi.org/10.1515/scid-2016-0002
Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma
Schlusser KE, Pilcher CD, Kallas EG, Santos BR, Deeks SG, Facente SN, Keating SM, Busch MP, Murphy G, Welte A, Quinn TC, Eshleman SH, Laeyendecker O

PLoS One

(2017)

https://doi.org/10.1371/journal.pone.0172283
Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D
Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O

AIDS Research and Human Retroviruses

(2015)

https://doi.org/10.1089/AID.2014.0081
Using tests for recent infection to estimate incidence: problems and prospects for HIV
Welte A, McWalter TA, Hallett TB, Laeyendecker O

Eurosurveillance

(2010)

https://doi.org/10.2807/ese.15.24.19589-en
Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward
Mastrorea TD, Kim A, Hallett TB, Rehle T, Welte A, Laeyendecker O, Oluoch T, Garcia Calleja JM

Journal of HIV/AIDS Surveillance and Epidemiology

(2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130510/